Biotech

Omni Bio Pharmaceutical's Commercial Strategy Is Reinforced by New Data Supporting the Expanded Use of Alpha-1 Antitrypsin in the Treatment of Medical Conditions Such as Type 1 Diabetes

DENVER, CO: ...

MethylGene Reports Third Quarter 2012 Financial Results and Provides Corporate Update

MONTREAL, CANADA: ...

Biota Pharmaceuticals Announces Appointment of New Executive Officers

ROCKVILLE, MD: ...

ProMetic Reports Its Third Quarter 2012 Highlights and Financial Results

LAVAL, QUEBEC, CANADA: - Q3 Revenues of $7.7 million - Q3 Net profit of $2.5 million ...

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012

NEW YORK, NY: Five Star Equities Provides Stock Research on Achillion Pharmaceuticals and Sequenom ...

Boston Therapeutics Names Jonathan B.Rome Chief Operating Officer

MANCHESTER, NH: Former CEO of ThePharmaNetwork and Ascend Laboratories to Accelerate Commercialization of SUGARDOWN(R) and Filing an ANDA for BTI-7 ...

Immunovative, Inc. Announces Expanded Collaboration With the University of Arizona to Investigate AlloStim(TM) and AlloVax(TM) in Leukemias and Cancers That Affect Children

NEW YORK, NY: ...

Horizon Pharma Announces Third Quarter 2012 Financial Results and Provides Business Update

DEERFIELD, IL: Conference Call and Webcast Today, November 13th, at 8:00 a.m. ET ...

Cytovance(R) Biologics, Inc. Announces Manufacturing Agreement With Selexys Pharmaceuticals, Corp. for Phase II Production of SelG1

OKLAHOMA CITY, OK: ...

Horizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Morning Stiffness in Patients With Active Rheumatoid Arthritis

DEERFIELD, IL: Reduction in Morning Stiffness Correlates With ACR20, DAS28 and HAQ-DI Response ...